OrthoPediatrics announces Global POISE Study reaches milestone of 600 implants

OrthoPediatrics (KIDS) announced a significant milestone in the ongoing Global POISE Study: more than 600 implants are now being observed across 300+ pediatric patients as part of this study. Global POISE is a multi-center, post-market, prospective clinical follow-up study, designed to assess the safety and efficacy of a range of OrthoPediatrics’ implant devices. This international study is focused on verifying implant survival and identifying any device-related adverse events. Launched in 2023, Global POISE now includes 13 active sites and growing, with data currently being collected from Canada, the United States, Australia, New Zealand and South Africa. The insights generated from this study will inform further refinement of OrthoPediatrics devices to meet the specific needs of growing children with orthopedic conditions.